Electron microscopic localization of corticotropin-releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala

Journal of Comparative Neurology

Volumn 512, Issue 3, 2009, Pages 323-335

  Treweek, Jennifer B ^a   Jaferi, Azra ^a   Colago, Eric E ^a   Zhou, Ping ^a   Pickel, Virginia M ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Autonomic; Autoregulation; Drug addiction; Limbic; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; ELECTRON MICROSCOPY; IMMUNOGOLD LABELING; IMMUNOREACTIVITY; MOUSE; NERVE ENDING; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SOMATIC CELL; STRESS; SYNAPTIC TRANSMISSION; ANIMAL; C57BL MOUSE; CHEMISTRY; MOUSE MUTANT; NERVE CELL; SYNAPSE; ULTRASTRUCTURE;

AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SYNAPSES;

EID: 59149105741     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21884     Document Type: Article

References (81)

1. Agnati LF, Bjelke B, Fuxe K. 2004. Volume transmission in the brain. Am Sci 80:362-374.
2. Asan E, Yilmazer-Hanke DM, Eliava M, Hantsch M, Lesch KP, Schmitt A. 2005. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 131:953-967.
3. Aston-Jones G, Delfs JM, Druhan J, Zhu Y. 1999. The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877:486-498.
4. Bagosi Z, Jaszberenyi M, Szabo G, Telegdy G. 2008. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala - an in vitro superfusion study. Brain Res Bull 75:15-17.
5. Bale TL, Vale WW. 2004. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557.
6. Behan DP, De Souza EB, Lowry PJ, Potter E, Sawchenko PE, Vale WW. 1995. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol 16:362-382.
7. Bittencourt JC, Sawchenko PE. 2000. Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system. J Neurosci 20:1142-1156.
8. Blank T, Nijholt I, Grammatopoulos DK, Randeva HS, Hillhouse EW, Spiess J. 2003. Corticotropin-releasing factor receptors couple to multiple G-proteins to activate diverse intracellular signaling pathways in mouse hippocampus: role in neuronal excitability and associative learning. J Neurosci 23:700-707.
9. Brunson KL, Grigoriadis DE, Lorang MT, Baram TZ. 2002. Corticotropinreleasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain. Exp Neurol 176:75-86.
10. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogoldsilver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
11. Chen Y, Brunson KL, Muller MB, Cariaga W, Baram TZ. 2000. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1)-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus. J Comp Neurol 420:305-323.
12. Childs GV, Morell JL, Niendorf A, Aguilera G. 1986. Cytochemical studies of corticotropin-releasing factor (CRF) receptors in anterior lobe corticotropes: binding, glucocorticoid regulation, and endocytosis of [biotinyl-Ser1]CRF. Endocrinology 119:2129-2142.
13. Childs GV, Westlund KN, Tibolt RE, Lloyd JM. 1991. Hypothalamic regulatory peptides and their receptors: cytochemical studies of their role in regulation at the adenohypophyseal level. J Electron Microsc Tech 19:21-41.
14. Contarino A, Papaleo F. 2005. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc Natl Acad Sci U S A 102:18649-18654.
15. Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W, Gold LH. 1999. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res 835:1-9.
16. Cook CJ. 2004. Stress induces CRF release in the paraventricular nucleus, and both CRF and GABA release in the amygdala. Physiol Behav 82:751-762.
17. Curtis AL, Bello NT, Connolly KR, Valentino RJ. 2002. Corticotropinreleasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J Neuroendocrinol 14:667-682.
18. Daniels WM, Richter L, Stein DJ. 2004. The effects of repeated intraamygdala CRF injections on rat behavior and HPA axis function after stress. Metab Brain Dis 19:15-23.
19. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ. 1985. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 5:3189-3203.
20. Erb S, Salmaso N, Rodaros D, Stewart J. 2001. A role for the CRFcontaining pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 158:360-365.
21. Erb S, Funk D, Le AD. 2005. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity. Neurosci Lett 383:209-214.
22. Farb CR, Aoki C, Milner T, Kaneko T, LeDoux JE. 1992. Glutamate immunoreactive terminals in the lateral amygdaloid nucleus: a possible substrate for emotional memory. Brain Res 593:145-158.
23. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
24. Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ. 2005. Stress and central urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol 509:145-153.
25. George O, Ghozland S, Azar MR, Cottone P, Zorrilla EP, Parsons LH, O'Dell LE, Richardson HN, Koob GF. 2007. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine selfadministration in nicotine-dependent rats. Proc Natl Acad Sci U S A 104:17198-17203.
26. Gray TS. 1993. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann N Y Acad Sci 697: 53-60.
27. Gray TS, Bingaman EW. 1996. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit Rev Neurobiol 10:155-168.
28. Gray TS, Magnuson DJ. 1992. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13:451-460.
29. Heinrichs SS, Menzaghi FF, Schulteis GG, Koob GG, Stinus LL. 1995. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6:74-80.
30. Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT. 1997. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Pept 71:15-21.
31. Henry BA, Lightman SL, Lowry CA. 2005. Distribution of corticotropinreleasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres. J Neuroendocrinol 17:135-144.
32. Iredale PA, Terwilliger R, Widnell KL, Nestler EJ, Duman RS. 1996. Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells. Mol Pharmacol 50:1103-1110.
33. Iredale PA, Alvaro JD, Lee Y, Terwilliger R, Chen YL, Duman RS. 2000. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. J Neurochem 74:199-208.
34. Ji G, Fu Y, Ruppert KA, Neugebauer V. 2007. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain 3:13.
35. Kasagi Y, Horiba N, Sakai K, Fukuda Y, Suda T. 2002. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J Neuroendocrinol 14:587-592.
36. Keck ME, Ohl F, Holsboer F, Muller MB. 2005. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Neurosci Biobehav Rev 29:867-889.
37. Lee S, Smith GW, Vale W, Lee KF, Rivier C. 2001. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Alcohol Clin Exp Res 25:427-433.
38. Lee MC, Cahill CM, Vincent JP, Beaudet A. 2002. Internalization and trafficking of opioid receptor ligands in rat cortical neurons. Synapse 43:102-111.
39. Leranth C, Pickel VM. 1989. Electron microscopic pre-embedding double immunostaining methods. In: Heimer L, Zaborszky L, editors. Neuroanatomical tract-tracing methods 2: recent progress, 1st ed. New York: Plenum Publishing. p 129-172.
40. Leroux P, Pelletier G. 1984. Radioautographic study of binding and internalization of corticotropin-releasing factor by rat anterior pituitary corticotrophs. Endocrinology 114:14-21.
41. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. 2001. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U S A 98:7570-7575.
42. Li S, Kirouac GJ. 2008. Projections from the paraventricular nucleus of the thalamus to the forebrain, with special emphasis on the extended amygdala. J Comp Neurol 506:263-287.
43. Liu J, Yu B, Neugebauer V, Grigoriadis DE, Rivier J, Vale WW, Shinnick-Gallagher P, Gallagher JP. 2004. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J Neurosci 24:4020-409.
44. Maj M, Turchan J, Smialowska M, Przewlocka B. 2003. Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala. Neuropeptides 37:105-110.
45. Meister B, Hokfelt T, Geffard M, Oertel W. 1988. Glutamic acid decarboxylase- and gamma-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology 48: 516-526.
46. Miyata I, Shiota C, Ikeda Y, Oshida Y, Chaki S, Okuyama S, Inagami T. 1999. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala. Biochem Biophys Res Commun 256:692-696.
47. Moga MM, Gray TS. 1985. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus. J Comp Neurol 241:275-284.
48. Muglia L, Jacobson L, Dikkes P, Majzoub JA. 1995. Corticotropinreleasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 373:427-432.
49. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR. 2004. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303:1512-1514.
50. Nitecka L, Frotscher M. 1989. Cholinergic-GABAergic synaptic interconnections in the rat amygdaloid complex: an electron microscopic double immunostaining study. EXS 57:42-49.
51. Olson VG, Zabetian CP, Bolanos CA, Edwards S, Barrot M, Eisch AJ, Hughes T, Self DW, Neve RL, Nestler EJ. 2005. Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25:5553-5562.
52. Paneda C, Winsky-Sommerer R, Boutrel B, De Lecea L. 2005. The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction. Drug News Perspect 18:250-255.
53. Paxinos G, Watson C. 1998. The Rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press.
54. Perrin MH, Vale WW. 1999. Corticotropin releasing factor receptors and their ligand family. Ann N Y Acad Sci 885:312-328.
55. Peters A, Palay SL, Webster Hd. 1991. The fine structure of the nervous system, 3rd ed. New York: Oxford University Press.
56. Pitkanen A, Amaral DG. 1994. The distribution of GABAergic cells, fibers, and terminals in the monkey amygdaloid complex: an immunohistochemical and in situ hybridization study. J Neurosci 14:2200-2224.
57. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W. 1994. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci U S A 91:8777-8781.
58. Quirk GJ, Gehlert DR. 2003. Inhibition of the amygdala: key to pathological states? Ann N Y Acad Sci 985:263-272.
59. Quirk GJ, Likhtik E, Pelletier JG, Pare D. 2003. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 23:8800-8807.
60. Radulovic J, Sydow S, Spiess J. 1998. Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res 54:507-521. Reyes BA, Valentino RJ, Van Bockstaele EJ. 2008. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons. Endocrinology 149:122-130.
61. Reynolds ES. 1963. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J Cell Biol 17:208.
62. Rivier J, Spiess J, Vale W. 1983. Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A 80:4851-4855.
63. Saha S, Batten TFC, Henderson Z. 2000. A gabaergic projection from the central nucleus of the amygdala to the nucleus of the solitary tract: a combined anterograde tracing and electron microscopic immunohistochemical study. Neuroscience 99:613-626.
64. Sakanaka M, Shibasaki T, Lederis K. 1986. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 382:213-238.
65. Sanchez MM, Young LJ, Plotsky PM, Insel TR. 1999. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408:365-377.
66. Santibanez M, Gysling K, Forray MI. 2005. Adrenalectomy decreases corticotropin-releasing hormone gene expression and increases noradrenaline and dopamine extracellular levels in the rat lateral bed nucleus of the stria terminalis. J Neurosci Res 81:140-152.
67. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W. 1993. The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 172:5-21.
68. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J. 1997. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17:2605-2614.
69. Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF. 1998. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102.
70. Sun N, Yi H, Cassell MD. 1994. Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala. J Comp Neurol 340:43-64.
71. Swanson LW, Sawchenko PE, Rivier J, Vale WW. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165-186.
72. Swinny JD, Kalicharan D, Blaauw EH, IJkema-Paassen J, Shi F, Gramsbergen A, Van der Want JJ. 2003. Corticotropin-releasing factor receptor types 1 and 2 are differentially expressed in pre- and postsynaptic elements in the post-natal developing rat cerebellum. Eur J Neurosci 18:549-562.
73. Van Bockstaele EJ, Colago EE, Valentino RJ. 1998. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response. J Neuroendocrinol 10:743-757.
74. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
75. Veening JG, Swanson LW, Sawchenko PE. 1984. The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: a combined retrograde transport-immunohistochemical study. Brain Res 303:337-357.
76. Wang J, Fang Q, Liu Z, Lu L. 2006. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshockstress-or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) 185:19-28.
77. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, De Lecea L. 2004. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439-11448.
78. Winsky-Sommerer R, Boutrel B, De Lecea L. 2005. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol Neurobiol 32: 285-294.
79. Wu JS, Ku YH, Li LS, Lu YC, Ding X, Wang YG. 1999. Corticotropin releasing factor and substance P mediate the nucleus amygdaloideus centralis-nucleus ventromedialis-nucleus dorsomedialis pressor system. Brain Res 842:392-398.
80. Zhao Y, Valdez GR, Fekete EM, Rivier JE, Vale WW, Rice KC, Weiss F, Zorrilla EP. 2007. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. J Pharmacol Exp Ther 323:846-854.
81. Zhou P, Qian L, Glickstein SB, Golanov EV, Pickel VM, Reis DJ. 2001. Electrical stimulation of cerebellar fastigial nucleus protects rat brain, in vitro, from staurosporine-induced apoptosis. J Neurochem 79:328-338.